Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07507708 · ClinicalTrials.gov registry record · NA
Insulin Delivery With Self-Adjusting Closed-Loop and Behavioral Glycemic Control Enhanced by Prediction
A NA study, sponsored by Sue Brown.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT07507708: Recruiting NA study, sponsored by Sue Brown.
NCT07507708 is a NA study that is actively recruiting participants, run by Sue Brown. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07507708, a NA study, is actively recruiting participants, sponsored by Sue Brown.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This study is a randomized cross-over trial comparing AIDANET with Anticipation to AIDANET in FCL without Anticipation. Participants will complete 4 weeks of AID data collection which will be used to establish baseline and initialize the control algorithm. Participants will then be randomized to one of two groups: Group A: AIDANET in FCL with Anticipation (AIDANET+ACL), and Group B: AIDANET in FCL without Anticipation (AIDANET+FCL). The study duration of each group is 4 weeks each. The order of these two phases will be dependent upon randomization.
Primary Outcome
Computed as the number of estimated glucose values ≥70mg/dL and \<140mg/dL divided by the number of valid values (defined as a number between 39 and 401)
Interventions
- DEVICE Automated Insulin Delivery (AID)
- DEVICE AIDANET + Fully Closed Loop (FCL)
- DEVICE AIDANET + Anticipatory Closed Loop (ACL)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-05-14 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT07507708 shows while recruiting
NCT07507708 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 3 interventions - of which Automated Insulin Delivery (AID) is the first listed.
NCT07507708 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07507708 about?
NCT07507708 is a clinical study titled "Insulin Delivery With Self-Adjusting Closed-Loop and Behavioral Glycemic Control Enhanced by Prediction". This study is a randomized cross-over trial comparing AIDANET with Anticipation to AIDANET in FCL without Anticipation. Participants will complete 4 weeks of AID data collection which will be used to establish baseline and initialize the control algorithm. Participants will then be randomized to one...
What is the current status of trial NCT07507708?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-05-14. Estimated completion is 2026-12-31.
What interventions are being tested in trial NCT07507708?
The interventions under investigation include: Automated Insulin Delivery (AID) (DEVICE), AIDANET + Fully Closed Loop (FCL) (DEVICE), AIDANET + Anticipatory Closed Loop (ACL) (DEVICE).
Who is sponsoring clinical trial NCT07507708?
This trial is sponsored by Sue Brown, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07507708's enrollment target sits among peer trials
20 1768th of 2000 higher than 140 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI